Table 1. Summary of the different parameters measured at the indicated time point in the trial.

Plasma	Baseline	BF 400 mg	BF 800 mg
Total cholesterol (mmol/L)	5.57±1.42	4.80±0.88**	4.85±0.84*
LDL(mmol/L)	3.67±1.17	2.93±0.80**	2.90±0.73*
HDL(mmol/L)	1.39±0.25	1.57±0.25***	1.64±0.26***
TG(mmol/L)	1.34±0.79	0.70±0.31**	0.71±0.22*
C22∶0(µmol/L)	43.32±9.25	45.37±8.12	55.02±9.74**
C24∶0(µmol/L)	62.56±11.68	64.08±11.78	82.62±12.50***
C26∶0(µmol/L)	3.26±0.96	2.56±0.50**	2.99±0.49
C26∶0/C22∶0 ratio	0.075±0.015	0.058±0.012	0.056±0.012**
Bezafibrate(µmol/L)	n.d.	n.d.	10.1±6.7
Lymphocytes
C22∶0(nmol/mg)	5.89±1.03	5.85±1.65	5.10±1.47
C24∶0(nmol/mg)	6.03±0.78	6.45±1.85	6.42±1.44
C26∶0(nmol/mg)	0.35±0.040	0.37±0.084	0.40±0.11
C26∶0/C22∶0 ratio	0.06±0.01	0.06±0.01	0.08±0.03
bloodspots
C26∶0 lysoPC	2.84±1.40	2.50±0.89	2.63±1.18
Weight (kg)	86.7±9.3	n.d.	87.9±10.5

Values are mean ± the standard deviation. Statistically significant differences from the baseline value are indicated.

^*p<0.05,

^**p<0.01,

^***p<0.001. n.d. = not determined.